Over the past few months, the Real4Reg partners have been actively engaging with the scientific community, participating in various international events to exchange insights and share our project. Here’s a brief recap of Real4Reg participation in 2023:
- The Real4Reg project was presented at the EUpALS Annual General Meeting in July, satellite to ENCALS 2023 (Barcelona, Spain), an opportunity to share our work with the members of 28 national ALS Associations from 22 European countries.
- In September, the Nova School of Business and Economics (Cascais, Portugal) hosted the “Data Use in Healthcare” conference, an event organised by INFARMED, I.P, as part of the celebration of its 30th anniversary. The Real4Reg project was introduced to a diverse audience, both in-person and online, at the presentation “Medicines policy underpinned by RWD”.
- Also in September, the 18th annual meeting of the German Society of Epidemiology, DGEpi (Würzburg, Germany) occurred under the theme “Epidemiology in Transition – Innovations and Challenges”. Real4Reg partners, from BfArM and DZNE, presented the Real4Reg project to an audience of researchers and academics from all over Germany.
- In November, the project was presented by BfArM at the DIA Innovating Clinical Trials in Europe Conference and at the DKMA and EFPIA Multi-Stakeholder Workshop on “Bridging the Gap: Exploring Real-World Data, Single-Arm Trials, and Comparative Effectiveness”. At both events representatives from the five MetReal cluster projects explored how real-world data can reshape regulatory decision-making and discussed the use of artificiaI intelligence.
- BfArM also presented our project at the 30th Annual Meeting of the German Drug Utilisation Research Group (Cologne, Germany) in November.
- Our project was also mentioned by our partner Fraunhofer SCAI in multiple events during the year: the German Data Science Days in March (Munich, Germany), the Data Science Summit in April (Bonn, Germany), the DKMA and EFPIA Multi-Stakeholder Workshop, and in the EMA Big Data Stakeholder Forum.
In 2024, the Real4Reg project and its partners will continue to share their expertise and insights fostering collaboration and innovation in the field of healthcare research and epidemiology.